
Sign up to save your podcasts
Or


Edmar Ferreira talks with Ryan McLinko, chief technology officer and co-founder of Astranis Space Technologies, which designs, builds, and operates smaller, lower-cost, geostationary communications satellites to connect unconnected people anywhere in the world.
In today’s episode, they talked about what the future looks like with Astranis, the technology that they have in Astranis, the connectivity that they created with their technology, and they also talked about why Ryan chose to study and work in space, and Ryan also shared that biotechnology is also the field that he is also interested. They also talked about the history of Astranis, how it started way back in 2015 and how the funding dynamic process when they started, and the type of areas on earth that are now connected, especially in the field of internet connectivity, and the small comms satellite for geostationary orbit. And Ryan also describes the difference between Astranis from other deep tech companies. Discover the best advise from Ryan McLinko for those start-up companies and much more!
Edmar Ferreira talks with Celine Halioua, CEO and Founder of Loyal, which she incorporated in 2019 at the age of 25. Loyal is a biotech startup developing drugs to increase canine healthspan.
In today’s episode, they talk about the mission and vision of Loyal and the future that Loyal is excited about. They also talked about the drugs that Loyal is developing that target extending the aging of dogs, and how Celine became an animal lover. Celine also shares that dogs are a better model of human aging in general and she also shared how they started Loyal in 2019. They also talked about the biggest thing that Celine surprised her the most when they started Loyal. Celine also shared the biggest difficulty in raising funds for a biotech company like Loyal, as well as the people that she is looking to work with at Loyal and much more! And find out what's her best advice with those who are starting a biotech company.
Edmar Ferreira talks with Adrián Ferrero, CEO, and co-founder of Biome Makers. Adrián is a self-described entrepreneur on a mission to improve the world, and prior to Biome Makers, Adrián founded three start-ups and worked as an innovation consultant for more than nine years.
In today’s episode, they talk about the vision of Biome Makers and how they started, including the bioindicator and the science behind the technology that they are using in Biome Makers. They also talked about the ecological relationship, how their technology optimizes farming practices, and how it increases crop yield and quality, as well as improves soil health. Adrián also shared some challenges and some tips for raising capital as they closed in Series B funding stage this year and he also shared all his experiences and educational background prior to Biome Makers, and much more!
Edmar Ferreira talks with Peter Schlecht, CEO and Founder of Braingrade. With Braingrade, they provide direct access to our brains and improve our cognitive abilities while helping millions of Alzheimer's patients.
In today’s episode, they talk about what the future looks like with Braingrade in 20 to 25 years, and the meaning of the smart brain with Braingrade in 10 years. They also talked about the story behind Braingrade, how they started, and why Peter started Braingrade, including the technology that they have with Braingrade and how it works with the human brain, how stimulation works, and the device that they are using. Peter also shared how did they raise their fund and their upcoming rounds, and they also talked about their next clinical trial, how’s the supply chain with neurotech, what surprised Peter when he started the journey of Braingrade, and much more!
Edmar Ferreira talks with Ivan Lee, CEO and Founder of Datasaur. He graduated with a Computer Science bachelor from Stanford University. He has spent the last 10 years as a product manager for Machine Learning and most recently at Apple.
In today’s episode, they talk about the background of data and natural language processing (NLP), the quadrillion of documents that they generated, including how labeling works, and how every NLP team will be reliant on Datasaur in the coming years. Ivan also discussed what Datasaur provides to NLP science and how Datasaur works. They also talk about on how Datasaur works with data privacy and the software with machine learning and NLP, including the data labeling process. Ivan also shared how they started with data labeling, and how he started to build Datasaur, and Ivan also shared the most recent AI company that they acquired and much more!
Edmar Ferreira talks with Maryam Ziaei, CEO of iSono Health which she co-founded with the vision to make proactive and personalized breast health monitoring accessible to all women everywhere. And she has over 14 years of experience in product and business development.
In today’s episode, they talk about the vision of iSono Health, how many screenings a woman undergoes for a breast cancer screening and the technology that they are using in iSono Health. They also talked about the difference between iSono Health’s technology compared to mammograms including their biggest problem and challenges in the adoption of their technology. Maryam also mentioned the statistics of how many women die every year because of breast cancer. And she also shared how they all started, as well as the reason why she started her own start-up company and much more!
Edmar Ferreira talks with George Skoptsov, President and CEO of H Quest Vanguard Inc., who spent more than a decade executing and leading development of breakthrough automation and robotics technologies for the energy and mining sectors.
In today’s episode, they talk about their mission in H Quest Vanguard and how they started, what is the big problem that they’re solving now, and the possible solution. They also talked about the roots of climate change, how CO2 emissions come, and the technology they have that can address all of these problems including the biggest first example in H Quest and how they deliver the zero issue to hydrogen using their process. And they also discussed if what's the cost today of using hydrogen versus using oil and coal and the ways to decarbonize industry and much more!
Edmar Ferreira talks with Auriane Gamelin, co-founder, and COO of OncoXome. Where she's focused on advancing cancer research to overcome its resistance.
In today’s episode, they talk about how Auriane’s father analyzed cancer cell communication and cancer resistance, she also explained what are cancer cell communications, and cancer is an ecosystem in which cell communication is highly present. Auriane also share how did she transition from her previous industry to the biotech industry. They also talk about how they hack those exosomes, how chemotherapy works, how they perform their studies with cancer cells, what is exosome homing, and much more!
Edmar Ferreira talks with Sebastian Bhakdi, doctor, a classically trained musician, founder, and CEO of X-ZELL.
In this new episode, they talk about the vision of X-ZELL, how the Pap test started and how it works, and its effectiveness in detecting cancer cells. They also talk about the technology catching cancer cells, how they started and develop cancer screening, the different negative and positive predictive values of cancer, and the challenge they get to the first level. They also discuss the typical customer of X-ZELL and go-to-market strategy, and the knowledge and lessons that Dr Sebastian uses as a startup founder & CEO, and much more!
Edmar Ferreira talks with Simon Melov, a founding faculty member of the Buck Institute, the first author of a landmark paper and aging, founding co-editor of Aging Cell, and now founder and CEO of Gerostate Alpha.
In this episode, they talk about the background story of Gerostate Alpha and how they started, what are their biggest technical challenges, how do they measure the progress of their team, what are the changes in 10 years once their vision succeeded, and how they track the problem of aging, Simon’s perspective on how long will aging is treatable, and how to speed up technological progress, and all the trends that Simon is following in deep tech, and much more!